Abstract

Crosstalk between the gut microbiome and the host plays an important role in animal development and health. Small compounds are key mediators in this host–gut microbiome dialogue. For instance, tryptophan metabolites, generated by biotransformation of tryptophan through complex host–microbiome co-metabolism can trigger immune, metabolic, and neuronal effects at local and distant sites. However, the origin of tryptophan metabolites and the underlying tryptophan metabolic pathway(s) are not well characterized in the current literature. A large number of the microbial contributors of tryptophan metabolism remain unknown, and there is a growing interest in predicting tryptophan metabolites for a given microbiome. Here, we introduce TrpNet, a comprehensive database and analytics platform dedicated to tryptophan metabolism within the context of host (human and mouse) and gut microbiome interactions. TrpNet contains data on tryptophan metabolism involving 130 reactions, 108 metabolites and 91 enzymes across 1246 human gut bacterial species and 88 mouse gut bacterial species. Users can browse, search, and highlight the tryptophan metabolic pathway, as well as predict tryptophan metabolites on the basis of a given taxonomy profile using a Bayesian logistic regression model. We validated our approach using two gut microbiome metabolomics studies and demonstrated that TrpNet was able to better predict alterations in in indole derivatives compared to other established methods.

Highlights

  • Publisher’s Note: MDPI stays neutralThe gut microbiome is a community of metabolically active microorganisms inhabiting all niches along the intestines that coevolves with its host

  • Our prediction found the alteration of IPA validated of tryptophan metabolites in comparison with metabolomics data and by ECmetabolomics identified by and the obligatory intermediate

  • We focused on improving our knowledge on tryptophan metabolism by integrating information from >5000 genome-scale metabolic models (GEMs), 14 databases, and >300 literature reports

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutralThe gut microbiome is a community of metabolically active microorganisms inhabiting all niches along the intestines that coevolves with its host. Dysbiosis leads to a shift in the production of various microbial metabolites which influence the physiology and immune status of the host [7] Among these bioactive metabolites, short-chain fatty acids (SCFAs, produced by bacteria from fermenting dietary fibers), secondary bile acids (originated in liver and transformed by gut microbiome), and tryptophan-derived metabolites are most well known. Microbes can degrade tryptophan to a range of indoles including indolelactate (ILA), indoleacetic acid (IAA), indolealdehyde (IAld), indoleacrylic acid (IA), and indolepropionate (IPA) These can activate the aryl hydrocarbon receptor (AhR), a transcription factor widely expressed by cells in the immune system, regulate intestinal homeostasis [8], with regard to jurisdictional claims in published maps and institutional affiliations

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call